The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000277.3(PAH):c.969+5G>A

CA229879

102915 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: 6024bb15-c9cd-49b5-af43-eacea55dd334
Approved on: 2019-12-22
Published on: 2019-12-22

HGVS expressions

NM_000277.3:c.969+5G>A
NM_000277.3(PAH):c.969+5G>A
NC_000012.12:g.102846890C>T
CM000674.2:g.102846890C>T
NC_000012.11:g.103240668C>T
CM000674.1:g.103240668C>T
NC_000012.10:g.101764798C>T
NG_008690.1:g.75713G>A
NG_008690.2:g.116521G>A
NM_000277.1:c.969+5G>A
NM_000277.2:c.969+5G>A
NM_001354304.1:c.969+5G>A
ENST00000307000.7:c.954+5G>A
ENST00000549247.6:n.728+5G>A
ENST00000551114.2:n.631+5G>A
ENST00000553106.5:c.969+5G>A
ENST00000635477.1:n.74-2459G>A
ENST00000635528.1:n.484+5G>A
More

Pathogenic

Met criteria codes 4
PM3_Very Strong PP3 PM2 PP4_Moderate

Evidence Links 6

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The c.969+5G>A variant in PAH has been reported in at least 4 individuals with classic PKU (BH4 deficiency excluded) (PP4_moderate; PMID: 24048906). This variant is absent in population databases (PM2). This variant has been detected in the homozygous state and in compound heterozygotes with at least 6 Pathogenic/Likely Pathogenic variants including A300S (ClinVar: 92751, Pathogenic), R176X (ClinVar: 102723, Pathogenic), c.168+5G>C (ClinVar 102606, Pathogenic), and c.913-7A>G (ClinVar: 102894, Likely Pathogenic), c.1066-11G>A (ClinVar: 607, Pathogenic), E280K (ClinVar 580, Pathogenic) (PM3_VeryStrong; PMID: 30159852, PMID:10947211, PMID:24048906, PMID:30389586, PMID:24368688). Computational prediction tools suggest that c.969+5G>A may impact the protein (PP3). In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM3_VeryStrong, PM2, PP3, PP4_Moderate.
Met criteria codes
PM3_Very Strong
From PMID: 30159852, 32 Iranian patients genetically diagnosed with PKU were identified with this variant. This includes 23 homozygotes with serum Phe 11-54 mg/dL: patients 73, 140, 142, 166, 237, 314, 341, 370, 390, 405, 422, 435, 446, 558, 563, 574, 582, 589, 591, 600, 601, 612, 613 (1pt). Another 9 compound heterozygous patients with unconfirmed phase were also identified. Two patients with genotype c.1066-11G>A (ClinVar: 607, Pathogenic);c.969+5G>A: patient 53 serum Phe 15 mg/dL and patient 564 serum Phe 5.4 mg/dL (1pt). Patient 562 with genotype c.168+5G>C (ClinVar 102606, Pathogenic);c.969+5G>A abd serum Phe 14.2 mg/dL (0.5pt). Four patients with genotype p.Arg176Ter (ClinVar: 102723, Pathogenic);c.969+5G>A: patient 260 serum Phe 20 mg/dL, patient 106 serum Phe 15 mg/dL, patient 584 serum Phe NA, patient 628 serum Phe 20 mg/dL (1.5pt for 3 patients with Phe levels). Patient 628 with genotype c.969+5G>A;p.L258R (not previously classified) and serum Phe NA, (0pt). And patient 196 with genotype p.E280K (ClinVar 580, Pathogenic);c.969+5G>A and serum Phe 21 mg/dL (0.5pt). This variant has also been identified in trans with variants ClinVar: 102894, Likely Pathogenic) 0.25pt (PMID: 24048906) and Ala300Ser (ClinVar: 92751, Pathogenic) 0.5pt (PMID: 10947211). TOTAL: At least 26 homozygotes plus compound heterozygotes with at least 6 different Likely Pathogenic/Pathogenic variants. 5.5pt

PP3
Human splice finder reports WT donor splice site broken at -14.54%, MaxEnt reports -79.87% variation.
PM2
Variant is absent from all gnomAD and 1000 Genomes populations.
PP4_Moderate
At least four probands have been reported with classic PKU (serum Phe levels >1200uM) and exclusion of BH4 deficiency.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.